Cisplatin-induced nephrotoxicity in patients with advanced neuroblastoma

Pediatr Blood Cancer. 2018 Sep;65(9):e27253. doi: 10.1002/pbc.27253. Epub 2018 May 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child
  • Child, Preschool
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects*
  • Creatinine / blood
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Infant
  • Kidney Diseases / blood
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / genetics
  • Male
  • Neuroblastoma / drug therapy*
  • Neuroblastoma / pathology
  • Organic Cation Transport Proteins / genetics
  • Organic Cation Transporter 2 / genetics
  • Polymorphism, Single Nucleotide

Substances

  • Antineoplastic Agents, Alkylating
  • Organic Cation Transport Proteins
  • Organic Cation Transporter 2
  • SLC22A2 protein, human
  • SLC47A1 protein, human
  • Creatinine
  • Cisplatin